Volume 134, Issue 1, Pages 8-14 (January 2008)

Slides:



Advertisements
Similar presentations
Don C. Rockey  Clinical Gastroenterology and Hepatology 
Advertisements

MyD88 Signaling in the Intestine: Dr Jekyll and Mr Hyde?
Abnormal Liver Tests and Fatty Liver on Ultrasound
Lipids in Liver Disease: Looking Beyond Steatosis
Pathogenesis of Liver Injury in Acute Liver Failure
Abhishek Chauhan, David H. Adams  Gastroenterology 
Volume 143, Issue 5, Pages (November 2012)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Huiqin He, Zhinong Jiang, Leimin Sun  Gastroenterology 
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Don C. Rockey  Clinical Gastroenterology and Hepatology 
Volume 150, Issue 1, Pages (January 2016)
Evaluation and Management of End-Stage Liver Disease in Children
Volume 144, Issue 5, Pages (May 2013)
Serologic Markers Do Not Predict Histologic Severity or Response to Treatment in Patients With Autoimmune Hepatitis  Vaibhav Mehendiratta, Pradnya Mitroo,
Is HCV Infection a Neurologic Disorder?
Outcomes Among Living Liver Donors
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection  Tobias Boettler, Robert Thimme  Gastroenterology 
How to Critically Read the GI Epidemiology Literature
Senescence: Not Just for Tumor Suppression
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Mechanisms of Hepatic Fibrogenesis
Volume 134, Issue 5, Pages (May 2008)
Clinical Challenges and Images in GI
Volume 141, Issue 6, Pages (December 2011)
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
The Bone Marrow and Liver Fibrosis: Friend or Foe?
Jean-Michel Pawlotsky  Gastroenterology 
I. Carmona, P. Cordero, J. Ampuero, A. Rojas, M. Romero-Gómez 
Pathogenesis of Liver Injury in Acute Liver Failure
Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases  Chien-Wei Lee, Yu-Fan Chen, Hao-Hsiang Wu,
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
Volume 146, Issue 5, Pages (May 2014)
Viral Hepatitis in Liver Transplantation
Michael J. Williams, Andrew D. Clouston, Stuart J. Forbes 
MyD88 Signaling in the Intestine: Dr Jekyll and Mr Hyde?
Obesity, Inflammation, and Insulin Resistance
An Unusual Case Presented With Multiple Liver Cystic Lesions
Barbara Jung, Jonas J. Staudacher, Daniel Beauchamp  Gastroenterology 
Abnormal Liver Tests and Fatty Liver on Ultrasound
Autophagy, Microbial Sensing, Endoplasmic Reticulum Stress, and Epithelial Function in Inflammatory Bowel Disease  Arthur Kaser, Richard S. Blumberg 
YAPping About Glutaminolysis in Hepatic Fibrosis
The 75th Diamond Anniversary of Gastroenterology: 1943–2018
Percy A. Knolle, Robert Thimme  Gastroenterology 
Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T- Cell Function in Inflammatory Bowel Disease  Deanna D. Nguyen, Scott.
Volume 150, Issue 3, Pages (March 2016)
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Antifibrotic therapy in chronic liver disease
Volume 133, Issue 2, Pages (August 2007)
Volume 150, Issue 7, Pages (June 2016)
Volume 132, Issue 2, (February 2007)
Volume 148, Issue 3, Pages (March 2015)
A New Treatment for Portal Hypertension?
Volume 150, Issue 7, Pages (June 2016)
Covering the Cover Gastroenterology
Lipids in Liver Disease: Looking Beyond Steatosis
The Dawning of a New Editorial Board for Gastroenterology
Volume 149, Issue 6, Pages (November 2015)
Volume 151, Issue 4, Pages (October 2016)
Richard Blumberg, Judy Cho, James Lewis, Gary Wu  Gastroenterology 
Covering the Cover Gastroenterology
Volume 132, Issue 5, Pages (May 2007)
Volume 142, Issue 6, Pages e4 (May 2012)
Changing of the Guards: 2011–2016 Gastroenterology Team
Statins: Old drugs as new therapy for liver diseases?
Volume 155, Issue 6, Pages (December 2018)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Controversies in Liver Transplantation for Hepatitis C
Presentation transcript:

Volume 134, Issue 1, Pages 8-14 (January 2008) Noninvasive Assessment of Liver Fibrosis and Portal Hypertension With Transient Elastography  Don C. Rockey  Gastroenterology  Volume 134, Issue 1, Pages 8-14 (January 2008) DOI: 10.1053/j.gastro.2007.11.053 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Hepatic fibrogenesis. In most diseases leading to fibrosis, injury, and subsequent inflammation are prominent. Injury, typically involving epithelial cells (hepatocytes in the liver), leads to activation of immune cells and an inflammatory response. Inflammatory mediators, but also changes in the extracellular milieu, are an important stimulus for stellate cell activation and thus fibrogenesis. Importantly, once activated, the stellate cell activation arm becomes self-perpetuating via various autocrine systems. Although stellate cells appear to be the most critical effectors of fibrogenesis, other cell types (portal fibroblasts, fibrocytes), also appear to be important. Gastroenterology 2008 134, 8-14DOI: (10.1053/j.gastro.2007.11.053) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 The figure depicts an overview of the technique. Briefly, a pulse-echo ultrasound signal is obtained by placing a transducer probe between ribs over the right lobe of the liver. The low amplitude signal transmitted to the liver induces an elastic shear wave that propagates through liver tissue. The pulse-echo ultrasound allows measurement of wave velocity obtained provides a measure of liver stiffness. Gastroenterology 2008 134, 8-14DOI: (10.1053/j.gastro.2007.11.053) Copyright © 2008 AGA Institute Terms and Conditions